tickrz reports
tickrz rank
A
Cigna Corp (CI)
Healthcare | Health Services
184.97  -0.62%
FACTOR RANKINGSFACTOR SCREENER 
tickrz RankA / 22Warren Buffett RankA / 23
Pure Value RankA / 86Dividend RankC / 262
Moat RankB / 187Financial Strength RankN/A
Growth RankA / 68Momentum RankA / 24
CI vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
CISECTORS&P 500
P/E RATIO21.0331.619.61
EV/EBITDA RATIO5.616.911.89
P/S RATIO1.173.62.06
P/B RATIO3.255.53.15
QUALITY
RETURN ON EQUITY15.9%15.64%13.85%
RETURN ON CAPITAL%50.61%10.02%
NET MARGIN4.7%8.18%9.77%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.02%
PAYOUT RATION/A
3 YR DIVIDEND GROWTH0%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY32%
INTEREST COVERAGEN/Ax
CURRENT RATIO0.84
GROWTH
5 YR EPS GROWTH8.24%
5 YR SPS GROWTH12.54%
5 YR BPS GROWTH12.81%
About tickrz
Key Concepts
Great Investors
tickrz A-Ranked Cigna Corp scores well on valuation and momentum
tickrz rank A / 22
Cigna Corp receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
value
pure value ranking A / 86Warren Buffett ranking A / 23
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Cigna Corp's valuation score is comprised of a P/E ratio of 21x, a P/B ratio of 3.3x, a P/S ratio of 1.2x, and an EV/EBITDA ratio of 5.6x. Cigna Corp ranks 86 out of the S&P 500 constituents on valuation--a relatively strong score.Cigna Corp ranks 23 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Cigna Corp warrants further investigation.

quality
moat B / 187financial strength N/A
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.A debt/equity ratio of 32% and a Moat Rank of 187 translate to a not available Financial Strength score.


momentum A / 24
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 54.85% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 24. Cigna Corp's strong 12 month stock performance will appeal to momentum investors.

yield C / 262
value + yield
Shares currently yield 0.02%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Cigna Corp ranks 262 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

growth A / 68
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 8.2% 5 year annualized EPS growth, 12.5% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 12.8% speak to its impressive growth ranking.

Cigna Corp (CI)
Healthcare | Health Services
184.97  -0.62%


tickrz rank
A
VALUATION RATIOS
P/E Ratio21.03x
P/B Ratio3.25x
P/S Ratio1.17x
EV/EBITDA Ratio5.6x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.02%
PAYOUT RATION/A
3 YR DIVIDEND GROWTH0%
FINANCIAL STRENGTH
F SCORE NOT AVAILABLE
DEBT-TO-EQUITY32%
INTEREST COVERAGEN/Ax
CURRENT RATIO0.84
MOAT
ROE15.9%
ROIC
Net Margin4.7%
GROWTH
5 YR EPS GROWTH8.24%
5 YR SPS GROWTH12.54%
5 YR BPS GROWTH12.81%

TICKRZ RANK
Cigna Corp receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. Cigna Corp's valuation score is comprised of a P/E ratio of 21x, a P/B ratio of 3.3x, a P/S ratio of 1.2x, and an EV/EBITDA ratio of 5.6x. Cigna Corp ranks 86 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
Cigna Corp ranks 23 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, Cigna Corp warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.

FINANCIAL STRENGTH
A debt/equity ratio of 32% and a Moat Rank of 187 translate to a not available Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 54.85% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 24. Cigna Corp's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.02%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, Cigna Corp ranks 262 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 8.2% 5 year annualized EPS growth, 12.5% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 12.8% speak to its impressive growth ranking.